Note 16. Equity Incentive Plans and Employee Benefits (Tables)

9 Months Ended

Nov. 02, 2013

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

	Number of Options			Weighted Average Exercise Price Per Option
As of February 2, 2013		5,055,787		$	12.50
Granted		-			-
Exercised		(9,949	)		3.26
Cancelled or forfeited		(459,834	)		11.18
As of May 4, 2013		4,586,004		$	12.65
Granted		368,680			4.59
Exercised		(8,878	)		2.21
Cancelled or forfeited		(728,912	)		15.07
As of August 3, 2013		4,216,894		$	11.57
Granted		-			-
Exercised		(1,387	)		0.95
Cancelled or forfeited		(223,542	)		12.21
As of November 2, 2013		3,991,965		$	11.60
Options exercisable as of:
November 2, 2013		3,065,559		$	12.76

Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]

	Number of RSAs			Weighted Average Grant- Date Fair Value (Per RSA)		Aggregate Value
As of February 2, 2013		163,311		$	8.71	$	1,422,439
Granted		-			-
Vested		(6,588	)		9.50
Cancelled		(13,175	)		9.50
As of May 4, 2013		143,548		$	8.60	$	1,234,513
Granted		-			-
Vested		(10,980	)		6.83
Cancelled		-			-
As of August 3, 2013		132,568		$	8.75	$	1,159,970
Granted		-			-
Vested		-			-
Cancelled		-			-
As of November 2, 2013		132,568		$	8.75	$	1,159,970

	Number of RSUs			Weighted Average Grant-Date Fair Value (Per RSU)		Aggregate Value
As of February 2, 2013		632,262		$	6.28	$	3,970,605
Granted		37,675			4.65
Vested		(44,024	)		6.14
Cancelled		(75,582	)		6.39
As of May 4, 2013		550,331		$	6.16	$	3,390,039
Granted		143,536			5.12
Vested		(56,952	)		6.23
Cancelled		(49,411	)		6.36
As of August 3, 2013		587,504		$	5.88	$	3,455,878
Granted		4,675			5.14
Vested		(49,527	)		6.38
Cancelled		(14,347	)		5.84
As of November 2, 2013		528,305		$	5.83	$	3,080,018

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]

	Three Months Ended				Nine Months Ended
	November 2, 2013		October 27, 2012		November 2, 2013		October 27, 2012
Cost of revenue	$	64	$	131	$	214	$	380
Research and development expenses		778		1,375		2,721		4,346
Sales and marketing expenses		365		458		1,029		1,412
General and administrative expenses		461		539		1,423		1,940
Total stock-based compensation	$	1,668	$	2,503	$	5,387	$	8,078

Schedule of Defined Benefit Plans Disclosures [Table Text Block]

	Three Months Ended				Nine Months Ended
	November 2, 2013		October 27, 2012		November 2, 2013		October 27, 2012
Denmark	$	53	$	47	$	162	$	142
Taiwan		32		38		109		85
(*) The Netherlands		75		92		327		92
(*) Germany		12		-		66		-
Total matching contributions	$	172	$	177	$	664	$	319